$104M Euro fund

BioMedPartners closed its BioMedInvest II fund at CHF106 million ($104.2 million). The fund will focus on private early- to mid-stage healthcare companies in Germany, Switzerland and neighboring European countries.

BioMedPartners has over CHF250 million ($245.8 million) under management...